Skip to content

Clinical trials

Phase 2 Shock, Cardiogenic trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Shock, Cardiogenic Phase: Phase 2 Clear all

13 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20062
20081
20101
20152
20201
20221
20243
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting3
Completed3
Terminated2
Unknown status2
Not yet recruiting1
Active, not recruiting1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Brigham and Women's Hospital1
Corewell Health East1
Erasmus Medical Center1
Herzzentrum Goettingen1
Hospices Civils de Lyon1
IRCCS San Raffaele1
Mallinckrodt1
Martin-Luther-Universität Halle-Wittenberg1
Niguarda Hospital1
Rigshospitalet, Denmark1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Shock, Cardiogenic13
Heart Failure5
Inflammation2
Acute Coronary Syndrome1
Cardiomyopathies1
Heart Defects, Congenital1
Heart Diseases1
Hemorrhage1
Multiple Organ Failure1
ST Elevation Myocardial Infarction1

Trials

Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.